Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.4450 (-6.79%) ($8.4450 - $8.4450) on Mon. Aug. 7, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.52% (three month average) | RSI | 48 | Latest Price | $8.4450(-6.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.7% a day on average for past five trading days. | Weekly Trend | EDIT advances 1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(67%) ARKG(64%) IBB(56%) IWC(50%) ARKK(48%) | Factors Impacting EDIT price | EDIT will decline at least -2.26% in a week (0% probabilities). TBT(-23%) UUP(-14%) VXX(-4%) URA(-3%) VIXM(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.26% (StdDev 4.52%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.81 | 5 Day Moving Average | $8.93(-5.43%) | 10 Day Moving Average | $8.8(-4.03%) | 20 Day Moving Average | $8.81(-4.14%) | To recent high | -26.5% | To recent low | 5.5% | Market Cap | $524m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |